Navigation Links
Vermillion Announces Notice of Allowance of Patent for Breast Cancer Biomarkers
Date:2/2/2011

AUSTIN, Texas, Feb. 2, 2011 /PRNewswire/ -- Vermillion, Inc. (Nasdaq: VRML), a molecular diagnostics company, today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for a patent entitled "Biomarkers for breast cancer" to the Company. The patent claims are directed to biomarker combinations for the diagnosis and management of breast cancer and to the measurement of the biomarkers by mass spectrometry.

"The notice of allowance for this breast cancer biomarker patent is additional validation of our approach to intellectual property protection. We view the increasing breadth of our patent portfolio as a significant corporate asset," said Gail S. Page, CEO and Chairperson of the Board of Directors of Vermillion.

About Vermillion

Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, hematology, cardiology and women's health. Vermillion is based in Austin, Texas. Additional information about Vermillion can be found on the Web at www.vermillion.com.

Forward-Looking Statement

Certain matters discussed in this press release contain forward-looking statements that involve significant risks and uncertainties, including statements regarding Vermillion's plans, objectives, expectations and intentions. These forward-looking statements are based on Vermillion's current expectations. The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for such forward-looking statements. In order to comply with the terms of the safe harbor, Vermillion notes that a variety of factors could cause act
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Vermillion Announces Issuance of European Patent
2. Vermillion to Attend Society of Gynecologic Oncologists Meeting March 15-19
3. Medicare Establishes Reimbursement Coverage for Vermillions OVA1(TM) Test
4. Vermillion Announces Appointment of William C. Wallen, Ph.D. to Board of Directors
5. Vermillion Announces Return of Eric Fung, M.D., Ph.D.
6. Vermillion, Inc. Files a Voluntary Petition for Reorganization Relief Under Chapter 11 of the United States Bankruptcy Code
7. Vermillion Announces Notice of Issuance of U.S. Patent Covering Hepcidin as a Biomarker for Ovarian Cancer
8. Vermillion Announces Receipt of NASDAQ Panel Decision
9. Vermillion and Stanford Scientists Receive Best Research Award From the PAD Coalition
10. International Isotopes Inc. Announces a Shareholder Conference Call for February 7, 2011
11. Advanced Health Media Company Announces Renee DeFranco as Senior Vice President - Human Resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... CAMBRIDGE, Mass. , Feb. 27, 2015 /PRNewswire-USNewswire/ ... Analysis of the NCATS rare-diseases portfolio " in ... of a new financing technique to reduce the ... new diseases and potentially unlock new levels of ... The product of a unique collaboration between ...
(Date:2/27/2015)... DIEGO , Feb. 27, 2015  Pfenex Inc. ... the development of biosimilar therapeutics, today announced that it ... Francisco Marriott Marquis on March 2 nd at ... participate on a panel discussing the current state of ... of Biosimilars . For more information ...
(Date:2/26/2015)... S&P Capital IQ (MHFI) announced today that ... MabVax Therapeutics Holdings Inc . MabVax ... company focused on the development of vaccine and antibody-based ... of cancer. MabVax has discovered a pipeline of human ... generated by patients who have been immunized against targeted ...
(Date:2/26/2015)... 2015   Regulus Therapeutics Inc . (NASDAQ: ... and development of innovative medicines targeting microRNAs, today announced ... Chief Executive Officer of Regulus, will present a company ... Annual Healthcare Conference on Wednesday, March 4, 2015 at ... the Boston Marriott Copley Place.  The ...
Breaking Biology Technology:New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3
... NEW YORK, May 7 When leading contract research,organization ... system to a voice-over Internet protocol (VoIP),system that would ... nothing short of catastrophic., POI initially selected a ... but it was immediately clear the solution was a ...
... Carbon nanotubes potential as a super material is blighted ... take the form of an unprepossessing pile of sooty black ... in the University of Warwicks Department of Chemistry have found ... form a highly sensitive ready made electric circuit. , The ...
... Leading Venture Contest Makes Carnegie Mellon ,Winningest, ... ... team of,students from the Tepper School of Business at Carnegie Mellon have ... This year,s winning venture business -- NeuroBank -- has developed,a breakthrough proprietary ...
Cached Biology Technology:Pharm-Olam Finds VoIP Solution in Taridium LLC 2Nanotube production leaps from sooty mess in test tube to ready formed chemical microsensors 2Tepper School Team Takes Top Honors at Global Moot Corp(R) Competition 2
(Date:1/22/2015)... 2015 Valid S.A. ("Company") (BM&FBOVESPA: VLID3 ON), is pleased ... State of Washington,s Department of Licensing, ... and central issuance system for driver,s licenses and identification cards ... planning and development will start in January 2015, with enrollment ...
(Date:1/22/2015)... , Jan. 15, 2015  BellBrook Labs, a ... discovery, announced the launch of a TR-FRET (time ... company,s Transcreener UDP Assay, a high throughput screening ... new assay will allow for sensitive detection of ...
(Date:1/22/2015)... Jan. 21, 2015  Analyst Report Issued by Small Cap IR. ... showed that planet-wide, transactions at merchants on the leading payment ... number of credit, debit, and prepaid cards reached 6.54 billion.  ... of fraudulent card usage in 2012, and credit and debit ...
Breaking Biology News(10 mins):Valid USA Signs Contract For Washington Driver's License Issuance 2BellBrook Labs Launches a High Throughput Screening Assay for Glycosyltransferases with TR-FRET Readout 2$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2
... hybrid laboratory antibodies derived from chimpanzees and humans may ... the serious complications that can occur following smallpox vaccination--and ... The study, led by researchers with the National Institute ... National Institutes of Health (NIH), appears online this week ...
... the McKusick-Nathans Institute of Genetic Medicine at Johns Hopkins ... analyzing what many have termed "junk" DNA and identified ... found that these control regions from different species don't ... study will be published online at Science Express March ...
... state-of-the-art anti-aging technologies may extend human lifespans at an ... and economic challenges, says biologist Shripad Tuljapurkar of Stanford ... would have major implications for the global community in ... Professor of Population Studies, will give a talk Feb. ...
Cached Biology News:Mice studies illustrate potential of chimp/human antibodies to protect against smallpox 2Mice studies illustrate potential of chimp/human antibodies to protect against smallpox 3Junk DNA may not be so junky after all 2Junk DNA may not be so junky after all 3World faces challenge as life expectancies lengthen, scientist says 2World faces challenge as life expectancies lengthen, scientist says 3World faces challenge as life expectancies lengthen, scientist says 4
Vascular Endothelial Growth Factor C Class: Antibody Product Group: Angiogensis...
Annexin V Binding Buffer, 10X Concentrate Buffer , 50 ml Consult technical datasheet for details....
Mouse monoclonal [2A4] to Cytokeratin 8 + 18 + 19 ( Abpromise for all tested applications). Antigen: Cytokeratins isolated from cultured pig kidney epithelial cells. Entrez GeneID: 3856 S...
Tube-O-DIALYZER Floats, small....
Biology Products: